SA
XRPC

Strategic Advocates’s Canary XRP ETF XRPC Stock Holding History

Strategic Advocates’s Portfolio XRPC Stock Details XRPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$19.9K – 652
2025
Q4 		$19.9K Buy
+1,000
New +$21.6K 0.01% 291

Other funds holding XRPC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
JG
Jain Global New York $25.4B AUM 45.67% 1-Year Est. Return
KC
Kaleidoscope Capital Boston, Massachusetts $271M AUM 24.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Strategic Advocates's XRPC Position: Q1 2026 in Review

Strategic Advocates sold out of Canary XRP ETF (XRPC) in Q1 2026, closing a stake of 1,000 shares — an estimated $19.9K sold.

Strategic Advocates first reported a position in XRPC in Q4 2025 and held it in 1 quarter. The position peaked at $19.9K in Q4 2025. 40 funds tracked by Wall St. Rank hold XRPC as of Q1 2026.

  • Strategic Advocates reported no remaining Canary XRP ETF position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 1,000 Canary XRP ETF shares in Q1 2026, an estimated $19.9K.
  • Strategic Advocates first reported a position in Canary XRP ETF in Q4 2025 and held it in 1 quarter.
  • Strategic Advocates's Canary XRP ETF position peaked at $19.9K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Canary XRP ETF as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.